Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Suspected adverse reactions reported for Cadexomer-iodine
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Guidelines from the National Institute for Health and Care Excellence
NICE clinical guidance(3)
Leg ulcer infection: antimicrobial prescribing (NG152)
Topical antimicrobial dressings for locally infected leg ulcers: late-stage assessment (HTG751)
Chronic wounds: advanced wound dressings and antimicrobial dressings (ESMPB2)
Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 12 · Randomised trials: 8 · 1970–2024
Showing the 50 most relevant studies, sorted by most relevant.
Akira Yoshimura, V. Zhdankin
Chemical Reviews, 2024
Dun Lin, Yat Li
Advanced Materials, 2022
A. Hatch-McChesney, H. Lieberman
Nutrients, 2022
J. Köhrle
International Journal of Molecular Sciences, 2023
Hui Chen, Xiang Li, Keqing Fang, et al.
Advanced Energy Materials, 2023
Welham, Simon, Coneyworth, Lisa, Lisa Coneyworth, et al.
Cambridge University Press, 2023
Vegan and vegetarian diets are widely supported and adopted, but individuals following such diets remain at greater risk of iodine deficiency. This systematic review and meta-analysis was conducted to assess the iodine intake and status in adults following a vegan or vegetarian diet in the modern day. A systematic review and quality assessment were conducted from October 2020-December 2022 according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidance. Studies were identified in Ovid MEDLINE, Web of Science, PubMed, and Scopus. Eleven articles were eligible for review containing 4,421 adults (aged ≥ 18 years). Vegan groups had the lowest median urinary iodine concentration (mUIC) (12.2 L-1). None of the dietary groups had mUIC within the optimal range for iodine status (100-200 μg L-1) (World Health Organisation). Vegan diets had the poorest iodine intake (17.3 μg day-1) and were strongly associated with lower iodine intake (P = < 0.001) compared to omnivorous diets. Lower intake in vegan diets were influenced by gender (P = 0.007), the presence of voluntary or absence of Universal Salt Iodisation (USI) programmes (P = 0.01 P = < 0.001), and living in a country with adequate iodine nutrition (P = < 0.001). Vegetarians and particularly vegans, living in countries with no current USI programme continue to have increased risk of low iodine status, iodine deficiency and inadequate iodine intake. Further research into the usefulness of mandatory fortification of vegan appropriate foods is required
Abstract licence: CC BY
Xiaotian Guo, Hengyue Xu, Yijian Tang, et al.
Advanced Materials, 2024
Jin‐Lin Yang, Tuo Xiao, Tao Xiao, et al.
Advanced Materials, 2024
K. Woo, C. Dowsett, Ben Costa, et al.
International Wound Journal, 2021
Tong Liu, Yi Zhao, Min Song, et al.
Journal of the American Chemical Society, 2023
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.